vimarsana.com

Page 7 - நடுவில் அமெரிக்கா இதயம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca Suffers Diabetes Drug Setback For Covid-19

Low-Risk TAVR at 2 Years: Thrombosis Concerns Creep In

P=0.046) The TAVR group had had more deaths and strokes between 1 and 2 years compared with the SAVR group, according to the PARTNER 3 investigators led by Martin Leon, MD, of Columbia University Irving Medical Center in New York City. Their report was published in the March 9 issue of the Clearly, ongoing assessment of clinical and echocardiographic findings is needed in younger and low-risk patients and planned follow-up in PARTNER 3 will continue through at least 10 years, Leon and colleagues wrote. The convergence in death and stroke came as no surprise to cardiac surgeon Joseph Bavaria, MD, of the Hospital of the University of Pennsylvania in Philadelphia, who participated in the trial.

Concern raised over iPhone 12 potentially disabling implanted heart devices

Concern raised over iPhone 12 potentially disabling implanted heart devices Doctors are concerned the magnets in the iPhone 12 could disable implanted medical devices. and last updated 2021-02-17 08:23:51-05 KANSAS CITY, Mo. — Medical research has shown the new iPhone 12 could disable implanted heart devices, like the pacemaker or defibrillator. Findings from the Heart Rhythm Society reported internal magnets are so strong that the phone could interfere with the heart devices. The nonprofit focuses on cardiac rhythm disorders. In its report, it says, We hereby report an important public health issue concerning the newer-generation iPhone 12, which potentially can inhibit lifesaving therapy in a patient, particularly when the phone is carried in an upper chest pocket.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.